Chunfeng Zhao Selected Research

Lacerations

4/2007	An analysis of factors associated with failure of tendon repair in the canine model.
11/2004	Effect of gap size on gliding resistance after flexor tendon repair.
10/2004	Expression of growth factors in canine flexor tendon after laceration in vivo.
2/2004	Digital resistance and tendon strength during the first week after flexor digitorum profundus tendon repair in a canine model in vivo.
1/2004	Tendon surface modification by chemically modified HA coating after flexor digitorum profundus tendon repair.
7/2002	Reproducible volar partial lacerations in flexor tendons: a new device for biomechanical studies.
7/2002	Remodeling of the gliding surface after flexor tendon repair in a canine model in vivo.
6/2002	Treatment of partial lacerations in flexor tendons by trimming. A biomechanical in vitro study.
3/2002	Effect of synergistic motion on flexor digitorum profundus tendon excursion.
1/2002	Effect of synergistic wrist motion on adhesion formation after repair of partial flexor digitorum profundus tendon lacerations in a canine model in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunfeng Zhao Research Topics

Disease

12	Carpal Tunnel Syndrome 03/2021 - 11/2004
10	Fibrosis (Cirrhosis) 10/2021 - 03/2008
10	Lacerations 04/2007 - 01/2002
8	Tendon Injuries 10/2021 - 10/2004
4	Wounds and Injuries (Trauma) 01/2021 - 08/2007
3	Rupture 06/2013 - 04/2007
2	Osteoporosis 02/2018 - 01/2015
1	Rotator Cuff Injuries 01/2022
1	Postmenopausal Osteoporosis 02/2018
1	Femoracetabular Impingement 02/2017
1	Tendinopathy (Tendonitis) 02/2015
1	Congenital Abnormalities (Deformity) 01/2015
1	Edema (Dropsy) 03/2014
1	Osteoarthritis 02/2013
1	Hyperplasia 01/2013
1	Fatigue 04/2012
1	Cataract (Cataracts) 07/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2010
1	Scoliosis 08/2009
1	Demyelinating Diseases (Demyelinating Disease) 03/2008
1	Infections 01/2008
1	Tenosynovitis 08/2007

Drug/Important Bio-Agent (IBA)

8	CollagenIBA 05/2015 - 09/2005
5	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 03/2014 - 03/2008
3	formycin diphosphate (FDP)IBA 11/2010 - 07/2002
2	Collagen Type I (Type I Collagen)IBA 01/2019 - 03/2018
2	Connective Tissue Growth FactorIBA 03/2018 - 11/2014
2	salicylhydroxamic acid (SHAM)IBA 12/2011 - 02/2004
2	MetalsIBA 05/2010 - 08/2009
1	MicroRNAs (MicroRNA)IBA 10/2021
1	Actins (F Actin)IBA 03/2021
1	bindaritIBA 03/2021
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 03/2021
1	Inhibins (Inhibin)IBA 03/2021
1	LuciferasesIBA 03/2021
1	IntegrinsIBA 03/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2021
1	Endothelin-1 (Endothelin 1)IBA 03/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2021
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 09/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2018
1	Collagen Type III (Type III Collagen)IBA 03/2018
1	ErbB Receptors (EGF Receptor)IBA 03/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2018
1	SteroidsIBA 02/2018
1	ElementsIBA 02/2017
1	Collagenases (Collagenase)FDA Link 02/2015
1	Teriparatide (Parathar)FDA Link 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	cd-HA-lubricinIBA 06/2013
1	Hyaluronic Acid (Hyaluronan)IBA 02/2013
1	lubricinIBA 01/2013
1	trichostatin A (A 300)IBA 04/2012
1	AntioxidantsIBA 07/2011
1	Selenious Acid (Selenite)IBA 07/2011
1	Membrane Transport Proteins (Biological Pump)IBA 06/2010
1	PolyestersIBA 08/2009
1	SolutionsIBA 03/2008
1	GalactosidasesIBA 01/2008
1	Green Fluorescent ProteinsIBA 01/2008
1	Biological ProductsIBA 03/2005
1	Coloring Agents (Dyes)IBA 11/2004
1	ElastinIBA 11/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2004
1	Epidermal Growth Factor (EGF)IBA 10/2004
1	platelet-derived growth factor AIBA 10/2004
1	Dihydrotachysterol (AT 10)IBA 10/2004
1	Becaplermin (PDGF-BB)FDA Link 10/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004
1	Methylene Blue (Methylthioninium Chloride)FDA Link 07/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2002
4	Sutures (Suture) 01/2016 - 06/2002
2	Ovariectomy (Oophorectomy) 02/2018 - 01/2015
2	Injections 03/2014 - 07/2011
2	Suture Techniques 04/2007 - 11/2004
1	Operative Surgical Procedures 01/2018
1	Anesthesia 01/2018
1	Postoperative Care 01/2018
1	Pedicle Screws 01/2015
1	Tendon Transfer 08/2007